Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021 Year: 2021
Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population Source: Eur Respir J 2014; 44: 1363-1366 Year: 2014
Future trends in cystic fibrosis demography in 34 European countries Source: Eur Respir J 2015; 46: 133-141 Year: 2015
Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019
Oral health and some risk factors in children with cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020
Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020 Year: 2021
Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Differences in the quality of life of patients with chronic obstructive pulmonary disease living in different countries Source: Annual Congress 2011 - Physical activity, methodology and impact Year: 2011
Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020
Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019 Year: 2019
Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007
Structural determinants of long-term functional outcomes in young children with cystic fibrosis Source: Eur Respir J, 55 (5) 1900748; 10.1183/13993003.00748-2019 Year: 2020
Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021
Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Nurse-provided education improves adherence and quality of life in adult patients with cystic fibrosis Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020
Does lung transplantation affect on the improvement of psychological status in patients with adult cystic fibrosis? Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019